The WVU Cancer Institute’s Cancer Prevention and Control has expanded its Bridge Program that focuses on lung cancer survivorship to United Hospital Center (UHC) in Bridgeport. The goal of the Bridge Program is to improve the coordination of care and decrease the consequences of treatment for patients diagnosed with stage I, II, or III lung cancer after they complete treatment.
“It has been an exciting opportunity to be part of this project from the early stages with the WVU Cancer Institute, as a gap in care has been identified for the lung cancer survivors of West Virginia,” Linda Carte, RN, MSN, AOCN, vice president of oncology and post-acute care at United Hospital Center, said. “While lung cancer survivors are the first to have the opportunity to participate in this Bridge Program, it is a model that can certainly be extended to all those surviving cancer to improve quality of life after diagnosis and treatment. We are looking forward to this ongoing collaboration to improve cancer care for the many communities we serve.”
The Bridge Program brings together healthcare professionals from multiple disciplines to create a comprehensive care plan tailored to the specific needs of each patient. During a half-day clinic, each patient has the opportunity to meet individually with a nurse practitioner, licensed social worker, dietitian, psychiatrist, physical therapist, and occupational therapist.
The program is funded by the Bristol-Myers Squibb Foundation’s "Bridging Cancer Care" initiative.
The WVU Cancer Institute held its annual Pink Party event on Monday, September 10, to benefit Bonnie’s Bus, the mobile mammography unit that travels across West Virginia to provide mammograms to the women of the state.
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.